Voices
Antonio Lázaro Sánchez Shares ESMO 2026 Research on Cancer Clinical Trial Access
Antonio Lázaro Sánchez/LinkedIn

Antonio Lázaro Sánchez Shares ESMO 2026 Research on Cancer Clinical Trial Access

Antonio Lázaro Sánchez, Consultant Medical Oncologist at Hospital Clínico Universitario Virgen de la Arrixaca, shared a post on LinkedIn:

“Great news!

Our abstract, ‘Regional Inequality in Access to Cancer Clinical Trials and Cancer Mortality in Spain,’ has been accepted as a poster at ESMO 2026 in Madrid (October 23-27).

Why is this work important? Because a patient’s ZIP code shouldn’t determine their treatment options for cancer. We analyzed how regional differences in access to cancer clinical trials are related to cancer mortality in Spain.

A huge thank you to my co-authors.

If you’ll be at ESMO, stop by our poster! I’d love to chat about equity in cancer research.”

Antonio Lázaro Sánchez

Other articles about ESMO on OncoDaily.

access to care access to clinical trials Antonio Lázaro Sánchez cancer cancer clinical trials Cancer Epidemiology cancer mortality cancer outcomes Cancer Policy Cancer research clinical research clinical trials Equity in Cancer Research ESMO esmo 2026 European Society for Medical Oncology health equity Healthcare Disparities OncoDaily Oncology oncology research public health Regional Inequality